Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01859156
Other study ID # 06-2713
Secondary ID
Status Completed
Phase N/A
First received May 8, 2013
Last updated October 28, 2014
Start date October 2006
Est. completion date July 2014

Study information

Verified date October 2014
Source Minneapolis Medical Research Foundation
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.


Recruitment information / eligibility

Status Completed
Enrollment 151
Est. completion date July 2014
Est. primary completion date July 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Carbon monoxide exposure

Exclusion Criteria:

- Less than 18 years old

- Suicide attempt

- Unable to provide informed consent

- Pregnant

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Hennepin County Medical Center Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Minneapolis Medical Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary EtCO2 The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level. Immediately upon study enrollment, an average time of 30 minutes post arrival to the hospital. No
See also
  Status Clinical Trial Phase
Completed NCT05661045 - The Effect of Blood Carboxyhemoglobin Levels on Total Antioxidant (Tas), Total Oxidant(Tos), Hypoxia Inducible Factor-1a (hif1a) During Low-flow and Normal-flow Anesthesia